Skip to main content

FDA nominee, paid millions by industry, says he'll recuse himself if needed

By   
   March 30, 2017

President Trump has repeatedly slammed pharmaceutical companies for "getting away with murder" on soaring drug prices, but he and his nominee to head the Food and Drug Administration have pledged to ease industry regulations and speed approvals for medicines and other consumer products.

 

Full story


Get the latest on healthcare leadership in your inbox.